SecBot SecBot

BWAY

Brainsway Ltd.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. L3· CIK 0001505065 Healthcare & Medical Devices
$9.34 −0.77 (−7.62%)
Nov 16 4:00 PM ET · prev $10.11
Market cap
$411.3M
Small cap
Consensus
Buy
86% Buy or better · 7 analysts
Median target
$19.00
+103% · range $18.80–20.00
1 year
+23.1%
from $7.59 · Nov 17
30 days
−18.4%
from $11.44
52-week range
$7.25–17.17
−46% from high · low Nov 20
Avg volume 20D
124.9K
Nov 10 spike 497.7K
Short interest
199.4K
≈0.5% of shares · −11.8%
Days to cover
2.5
at average volume
Insider net
$0.00
0 buyers · 3 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
17
analyzed by SecBot
SecBot read MIXED 11 reports · 90 days
Balance 0 bearish · 2 bullish · 9 neutral oldest → newest, height = score
Avg score ·High conf. 5/11

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersMIXED

    No open-market sales.

  • InstitutionsMIXED

    Q2 2026: 5 added (0 new), 5 trimmed or exited.

  • AnalystsBULLISH

    6 of 7 rate it Buy or better. Every target is above the price.

  • EstimatesFLAT

    Current-quarter EPS estimate $0.087 → $0.087 over 90 days.

  • Short sellersSTEADY

    Short interest −11.8% to 199.4K shares. 2.5 days to cover, ≈0.5% of shares.

  • TrendDOWNTREND

    23% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYADD188,968$2.9M
ARK Investment Management LLCTRIM142,500$2.2M
SEI INVESTMENTS COTRIM119,717$1.9M
JPMORGAN CHASE & CODOUBLED96,807$1.5M
Tidal Investments LLCDOUBLED89,248$1.4M
CITADEL ADVISORS LLCTRIM47,519$737.0K
Trexquant Investment LPTRIM36,892$572.2K
NewEdge Advisors, LLCDOUBLED18,830$292.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

7 analysts
Buy 86% rate it Buy or better
Strong Buy3Buy3Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +103%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 19, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Sep 10, 2026BTIG
REITERATE
REITERATEBuy
Sep 8, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Aug 31, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Aug 13, 2026Ladenburg Thalmann
MAINTAIN
MAINTAINBuy
Aug 12, 2026BTIG
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$0
sold · 3 insiders
DateInsiderTypeValue
Jun 15, 2026
Moiseyev Gilad
Chief Technology Officer
Jun 15, 2026
SELL5,000 sh
Jun 2, 2026
Roth Yiftach
Chief Scientist
Jun 2, 2026
SELL1,000 sh
Jun 2, 2026
Roth Yiftach
Chief Scientist
Jun 2, 2026
SELL2,000 sh
Jun 1, 2026
Roth Yiftach
Chief Scientist
Jun 1, 2026
SELL2,000 sh
May 26, 2026
Mitrany Rayten Michal Ety
Director
May 26, 2026
SELL7,980 sh
May 25, 2026
Mitrany Rayten Michal Ety
Director
May 25, 2026
SELL10,000 sh
May 25, 2026
Moiseyev Gilad
Chief Technology Officer
May 25, 2026
EXERCISE7,500 sh
May 25, 2026
Moiseyev Gilad
Chief Technology Officer
May 25, 2026
TAX W/H1,902 sh

Earnings setup

Estimates
$0.09
EPS estimate, this quarter
0%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.09$0.07–$0.12+0.0%$19.0M
Next Q$0.11$0.09–$0.14+0.0%$19.6M
Current FY$0.25$0.25–$0.25-18.5%$69.8M
Next FY$0.50$0.37–$0.75-1.3%$85.8M

Short side

FINRA· Oct 30, 2026
199,353
shares short
-11.8%
vs prior settlement
2.5
days to cover
≈0.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

17 filings · 7 press releases · 8 bullish · 0 bearish · 9 neutral
All BWAY filing & press-release reports (24)